Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Della Porta

Showing results (71-80 of 236) with videos related to

Pageof 24
Sort By:
Histopathology|October 25, 2024
Future directions in myelodysplastic syndromes/neoplasms and acute myeloid leukaemia classification: from blast counts to biologyMatteo G Della Porta, Jan Philipp Bewersdorf, Yu-Hung Wang, et al.
Carcinogenesis|July 1, 1990
Negative results of short-term genotoxicity tests with 1,4-bis[2-(3,5-dichloropyridyloxy)]benzeneT A Dragani, R Barale, S Parodi, et al.
The Journal of Clinical Investigation|April 1, 1993
Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid glandR Donghi, A Longoni, S Pilotti, et al.
Tumori|February 28, 1979
Antibody binding to membrane of cultured melanoma cells by sera of melanoma patientsS Canevari, G Fossati, P Vezzoni, et al.
Carcinogenesis|June 1, 1990
Transgenic mice containing hepatitis B virus sequences are more susceptible to carcinogen-induced hepatocarcinogenesisT A Dragani, G Manenti, H Farza, et al.
Journal of Pharmaceutical Sciences|September 17, 2010
Albumin/gentamicin microspheres produced by supercritical assisted atomization: optimization of size, drug loading and releaseG Della Porta, R Adami, P Del Gaudio, et al.
Oncogene|February 1, 1992
TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomasA Greco, M A Pierotti, I Bongarzone, et al.
Cancer Research|April 1, 1986
Expression of retroviral sequences and oncogenes in murine hepatocellular tumorsT A Dragani, G Manenti, G Della Porta, et al.
Haematologica|January 25, 2012
Clinical evaluation of extra-hematologic comorbidity in myelodysplastic syndromes: ready-to-wear versus made-to-measure toolMatteo G Della Porta, Ilaria Ambaglio, Marta Ubezio, et al.
Haematologica|August 4, 2011
Flow-FISH evaluation of telomere length in Philadelphia-negative myeloproliferative neoplasmsChiara Elena, Elisa Rumi, Monica Portolan, et al.
Pageof 24

Showing results (71-80 of 236) with videos related to

Sort By:
Pageof 24
Histopathology|October 25, 2024
Future directions in myelodysplastic syndromes/neoplasms and acute myeloid leukaemia classification: from blast counts to biologyMatteo G Della Porta, Jan Philipp Bewersdorf, Yu-Hung Wang, et al.
Carcinogenesis|July 1, 1990
Negative results of short-term genotoxicity tests with 1,4-bis[2-(3,5-dichloropyridyloxy)]benzeneT A Dragani, R Barale, S Parodi, et al.
The Journal of Clinical Investigation|April 1, 1993
Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid glandR Donghi, A Longoni, S Pilotti, et al.
Tumori|February 28, 1979
Antibody binding to membrane of cultured melanoma cells by sera of melanoma patientsS Canevari, G Fossati, P Vezzoni, et al.
Carcinogenesis|June 1, 1990
Transgenic mice containing hepatitis B virus sequences are more susceptible to carcinogen-induced hepatocarcinogenesisT A Dragani, G Manenti, H Farza, et al.
Journal of Pharmaceutical Sciences|September 17, 2010
Albumin/gentamicin microspheres produced by supercritical assisted atomization: optimization of size, drug loading and releaseG Della Porta, R Adami, P Del Gaudio, et al.
Oncogene|February 1, 1992
TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomasA Greco, M A Pierotti, I Bongarzone, et al.
Cancer Research|April 1, 1986
Expression of retroviral sequences and oncogenes in murine hepatocellular tumorsT A Dragani, G Manenti, G Della Porta, et al.
Haematologica|January 25, 2012
Clinical evaluation of extra-hematologic comorbidity in myelodysplastic syndromes: ready-to-wear versus made-to-measure toolMatteo G Della Porta, Ilaria Ambaglio, Marta Ubezio, et al.
Haematologica|August 4, 2011
Flow-FISH evaluation of telomere length in Philadelphia-negative myeloproliferative neoplasmsChiara Elena, Elisa Rumi, Monica Portolan, et al.
Pageof 24